How to calculate basal and bolus insulin regimen in a Diabetic Ketoacidosis (DKA) patient with a current Random Blood Sugar (RBS) of 124 mg/dL, initial RBS of 513 mg/dL, and total insulin given of 160 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Basal-Bolus Insulin Regimen After DKA Resolution

Administer basal insulin 2-4 hours before stopping IV insulin at 80% of the total insulin requirement over the last 6 hours, then divide the remaining 20% as prandial insulin across meals.

Calculating Your Patient's Insulin Requirements

Step 1: Determine Total Daily Dose (TDD)

  • Your patient received 160 units total during DKA treatment 1
  • Calculate the hourly insulin requirement during the last 6 hours of IV insulin infusion when glucose was stable 1
  • Multiply this hourly rate by 24 to estimate TDD 1
  • Example calculation: If the patient was receiving 5 units/hour in the final 6 hours → 5 × 24 = 120 units TDD

Step 2: Calculate Basal Insulin Dose

  • Give 50% of TDD as basal insulin (long-acting analog like glargine or detemir) 1
  • Using the example above: 120 units × 0.5 = 60 units of basal insulin daily 1
  • Critical timing: Administer this basal insulin 2-4 hours before discontinuing IV insulin to prevent rebound hyperglycemia and recurrent ketoacidosis 1

Step 3: Calculate Prandial (Bolus) Insulin Dose

  • Give 50% of TDD divided across three meals as rapid-acting insulin (lispro, aspart, or glulisine) 1
  • Using the example: 120 units × 0.5 = 60 units total prandial ÷ 3 meals = 20 units per meal 1
  • Alternatively, distribute based on meal size: 40% before breakfast, 30% before lunch, 30% before dinner 1

Step 4: Add Correction Scale

  • Use the 1800 rule to calculate correction factor: 1800 ÷ TDD 2
  • Example: 1800 ÷ 120 = correction factor of 15 (1 unit lowers glucose by ~15 mg/dL) 2
  • Target glucose 100-180 mg/dL in the post-DKA period 1, 2

Specific Regimen for Your Patient

Given current glucose of 124 mg/dL (near target), here's the practical approach:

Basal Insulin

  • Calculate average hourly insulin rate from last 6 hours of IV infusion 1
  • Multiply by 24, then take 50% for basal dose 1
  • Administer 2-4 hours before stopping IV insulin 1

Prandial Insulin

  • Take remaining 50% of calculated TDD 1
  • Divide by 3 meals: approximately 15-20 units per meal for most patients transitioning from DKA 1
  • Give before each meal with rapid-acting insulin 1

Correction Scale (Supplemental)

  • Blood glucose 150-200 mg/dL: 2 units 2
  • Blood glucose 201-250 mg/dL: 4 units 2
  • Blood glucose 251-300 mg/dL: 6 units 2
  • Blood glucose 301-350 mg/dL: 8 units 2
  • Blood glucose >350 mg/dL: 10 units and notify provider 2

Critical Pitfalls to Avoid

Timing Errors

  • Never stop IV insulin abruptly without prior subcutaneous basal insulin administration—this causes rebound hyperglycemia and recurrent DKA 1
  • The 2-4 hour overlap is essential because subcutaneous basal insulin takes time to reach therapeutic levels 1

Dosing Errors

  • Do not use the total 160 units given during acute DKA as your TDD—this represents crisis management, not maintenance needs 1
  • Use only the stable hourly rate from the last 6 hours when glucose was controlled 1
  • Recent evidence shows that adding low-dose basal insulin (0.2 units/kg) during IV insulin infusion prevents rebound hyperglycemia 1, 3

Monitoring Requirements

  • Check glucose every 2-4 hours initially after transition 1
  • Adjust doses by 10-20% if hypoglycemia occurs without clear cause 1, 2
  • If A1C remains above goal after stabilization, consider adding GLP-1 receptor agonist to the regimen 1

Alternative Approach for Mild-Moderate DKA

Recent evidence supports using subcutaneous insulin from the start in uncomplicated DKA: single doses of glargine (0.2 units/kg) and lispro (0.2 units/kg) initially, followed by lispro (0.1-0.2 units/kg) every 3 hours until resolution 3. This approach achieved 90% DKA resolution within 12 hours with comparable safety to IV insulin 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.